Education
About Us
Working with TipRanks
Follow Us
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
Earnings Data
Report Date
Nov 04, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.13Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, as Nautilus Biotechnology achieved significant scientific milestones, established strategic collaborations, and demonstrated strong financial management. However, there are challenges in terms of market development for proteoforms and limited immediate revenue generation from current collaborations.Company Guidance
Significant Scientific Milestone Achieved
Nautilus publicly shared its first preprint featuring novel data using the Nautilus platform, showcasing unprecedented dynamic range and industry-leading reproducibility in proteoform data.
Proteoform Analysis Breakthrough
The Nautilus platform demonstrated the ability to measure proteoforms at a single molecule level, offering insights into tau biology and potential advancements in neurodegenerative disease diagnostics and therapeutics.
Successful Collaborations Established
Nautilus signed two collaborations with major U.S. research institutes to demonstrate platform capabilities and enable new biological insights in Alzheimer's disease.
Strong Financial Management
Operating expenses for Q2 2025 were $17.1 million, an 18% decrease from the same period in 2024, with a net loss of $15.0 million compared to $18.0 million in the prior year.
Solid Cash Position
The company ended the quarter with approximately $179.5 million in cash, cash equivalents, and investments, projecting a cash runway through 2027.
NAUT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NAUT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 31, 2025 | $0.76 | $0.76 | 0.00% |
Apr 29, 2025 | $0.68 | $0.73 | +7.35% |
Feb 27, 2025 | $1.43 | $1.17 | -18.18% |
Oct 29, 2024 | $2.81 | $2.77 | -1.42% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Nautilus Biotechnolgy (NAUT) report earnings?
Nautilus Biotechnolgy (NAUT) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).
What is Nautilus Biotechnolgy (NAUT) earnings time?
Nautilus Biotechnolgy (NAUT) earnings time is at Nov 04, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NAUT EPS forecast?
NAUT EPS forecast for the fiscal quarter 2025 (Q3) is -0.15.